1. Miki, Y, Swensen, J, Shattuck-Eidens, D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66–71.
Google Scholar | Crossref | Medline | ISI2. Wooster, R, Bignell, G, Lancaster, J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789–792.
Google Scholar | Crossref | Medline | ISI3. Wang, F, Fang, Q, Ge, Z, et al. Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review. Mol Biol Rep 2012; 39: 2109–2118.
Google Scholar | Crossref | Medline4. Kuusisto, KM, Bebel, A, Vihinen, M, et al. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Breast Cancer Res 2011; 13: R20.
Google Scholar | Crossref | Medline5. World Health Organization (2015) Global Status Report on Noncommunicable Diseases 2014. https://books.google.com/books/about/Global_Status_Report_on_Noncommunicable.html?hl=&id=INoOrgEACAAJ
Google Scholar6. Shin, HR, Carlos, MC, Varghese, C. Cancer control in the Asia Pacific region: current status and concerns. Jpn J Clin Oncol 2012; 42: 867–881.
Google Scholar | Crossref | Medline7. Valencia, OM, Samuel, SE, Viscusi, RK, et al. The Role of Genetic Testing in Patients With Breast Cancer. JAMA Surg 2017; 152: 589.
Google Scholar | Crossref | Medline8. Leong, SPL, Shen, ZZ, Liu, TJ, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg 2010; 34: 2308–2324.
Google Scholar | Crossref | Medline | ISI9. Al-Moundhri, MS, Al-Ansari, A, Al-Mawali, K, et al. BRCA1 gene Molecular Alterations in Omani Breast Cancer Patients. Gulf J Oncolog 2013; 1: 45–51.
Google Scholar | Medline10. Giordano, A, Normanno, N. Breast Cancer in the Post-Genomic Era. Springer Science & Business Media, 2009.
Google Scholar | Crossref11. Seong, MW, Cho, S, Noh, DY, et al. Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation. Clin Genet 2009; 76: 152–160.
Google Scholar | Crossref | Medline12. Marchina, E, Fontana, MG, Speziani, M, et al. BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management. Oncol Rep 2010; 24: 1661–1667.
Google Scholar | Crossref | Medline13. Ford, D, Easton, DF, Bishop, DT, et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343: 692–695.
Google Scholar | Crossref | Medline | ISI14. Breast Cancer Linkage Consortium . Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999; 91: 1310–1316.
Google Scholar | Crossref | Medline15. Rashid, MU, Muhammad, N, Naeemi, H, et al. Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study. Hered Cancer Clin Pract 2019; 17: 27.
Google Scholar | Crossref | Medline16. CIA . The world factbook ; 2014. https://wwwciagov/library/publications/the-world-factbook/geos/bghtml/
Google Scholar17. Shetty, P. India faces growing breast cancer epidemic. Lancet 2012; 379: 992–993.
Google Scholar | Crossref | Medline | ISI18. Da Costa Vieira, RA, Biller, G, Uemura, G, et al. Breast cancer screening in developing countries. Clinics 2017; 72: 244–253.
Google Scholar | Crossref | Medline19. Ramathuba, DU, Ratshirumbi, CT, Mashamba, TM. Knowledge, attitudes and practices toward breast cancer screening in a rural South African community. Curationis 2015; 38: 1172.
Google Scholar | Crossref20. Moore, MA, Shin, HR, Curado, MP, et al. Establishment of an Asian Cancer Registry Network - problems and perspectives. Asian Pac J Cancer Prev 2008; 9: 815–832.
Google Scholar | Medline21. Akter, H, Sultana, N, Martuza, N, et al. Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort. BMC Med Genet 2019; 20: 150.
Google Scholar | Crossref | Medline22. Kumar, BV, Lakhotia, S, Ankathil, R, et al. Germline BRCA1 mutation analysis in Indian breast/ovarian cancer families. Cancer Biol Ther 2002; 1: 18–21.
Google Scholar | Crossref | Medline23. Saxena, S, Szabo, CI, Chopin, S, et al. BRCA1 and BRCA2 in Indian breast cancer patients. Hum Mutat 2002; 20: 473–474.
Google Scholar | Crossref | Medline24. Hedau, S, Jain, N, Husain, SA, et al. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res Treat 2004; 88: 177–186.
Google Scholar | Crossref | Medline25. Saxena, S, Chakraborty, A, Kaushal, M, et al. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet 2006; 7: 75.
Google Scholar | Crossref | Medline26. Syamala, V, Sreeja, L, Syamala, VS, et al. Novel germline mutations in BRCA2 gene among 96 hereditary breast and breast–ovarian cancer families from Kerala, South India. J Cancer Res Clin Oncol 2007; 133: 867–874.
Google Scholar | Crossref | Medline27. Vaidyanathan, K, Lakhotia, S, Ravishankar, HM, et al. BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation. J Biosci 2009; 34: 415–422.
Google Scholar | Crossref | Medline28. Soumittra, N, Meenakumari, B, Parija, T, et al. Molecular genetics analysis of hereditary breast and ovarian cancer patients in India. Hered Cancer Clin Pract 2009; 7: 13.
Google Scholar | Crossref | Medline29. Juwle, A, Saranath, D. BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity. Med Oncol 2012; 29: 3272–3281.
Google Scholar | Crossref | Medline30. Pandey, AKSA. BRCA1 Gene’s EXON 11 and Breast Carcinoma: A Mutational Hot Spot for Familial Patients and Prone to Metastases in Northern India. Journal of Clinical and Experimental Pathology 2015; 5: 1–6.
Google Scholar | Crossref31. Mannan, AU, Singh, J, Lakshmikeshava, R, et al. Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India. J Hum Genet 2016; 61: 515–522.
Google Scholar | Crossref | Medline32. Darooei, M, Poornima, S, Salma, BU, et al. Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population. Tumour Biol 2017; 39: 1010428317694303.
Google Scholar | SAGE Journals | ISI33. Mehta, A, Vasudevan, S, Sharma, SK, et al. Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India. Cancer Manag Res 2018; 10: 6505–6516.
Google Scholar | Crossref | Medline34. Shah, ND, Shah, PS, Panchal, YY, et al. Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients. Appl Clin Genet 2018; 11: 59–67.
Google Scholar | Crossref | Medline35. Liede, A, Malik, IA, Aziz, Z, et al. Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 2002; 71: 595–606.
Google Scholar | Crossref | Medline36. Rashid, MU, Zaidi, A, Torres, D, et al. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer 2006; 119: 2832–2839.
Google Scholar | Crossref | Medline37. Moatter, T, Aban, M, Khan, S, et al. BRCA1 status in Pakistani breast cancer patients with moderate family history. J Coll Physicians Surg Pak 2011; 21: 680–684.
Google Scholar | Medline38. Silva, WD, De Silva, W, Karunanayake, EH, et al. Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals. BMC Cancer 2008; 8: 214.
Google Scholar | Crossref | Medline39. Silva, SD, De Silva, S, Tennekoon, KH, et al. Novel and reported pathogenic variants in exon 11 of BRCA2 gene in a cohort of Sri Lankan young breast cancer patients. Fam Cancer 2017; 16: 329–338.
Google Scholar | Crossref | Medline40. Han, SA, Kim, SW, Kang, E, et al. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study. Fam Cancer 2013; 12: 75–81.
Google Scholar | Crossref | Medline41. Hartikainen, JM, Kataja, V, Pirskanen, M, et al. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families. Clin Genet 2007; 72: 311–320.
Google Scholar | Crossref | Medline42. Ikeda, N, Miyoshi, Y, Yoneda, K, et al. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 2001; 91: 83–88.
Google Scholar | Crossref | Medline43. Janavičius, R, Rudaitis, V, Mickys, U, et al. Comprehensive BRCA1 and BRCA2 mutational profile in Lithuania. Cancer Genet 2014; 207: 195–205.
Google Scholar | Crossref | Medline44. Thomassen, M, Gerdes, AM, Cruger, D, et al. Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark. Cancer Genet Cytogenet 2006; 168: 168–171.
Google Scholar | Crossref | Medline45. Bu, R, Siraj, AK, Al-Obaisi, KAS, et al. Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis. Int J Cancer 2016; 139: 1091–1097.
Google Scholar | Crossref | Medline46. Kim, H, Choi, DH. Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer. J Breast Cancer 2013; 16: 357.
Google Scholar | Crossref | Medline47. Anglian Breast Cancer Study Group . Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 2000; 83: 1301–1308.
Google Scholar | Crossref | Medline | ISI48. Kwong, A, Shin, VY, Ho, JCW, et al. Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. J Med Genet 2016; 53: 15–23.
Google Scholar | Crossref | Medline49. Lang, GT, Shi, JX, Hu, X, et al. The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing. Int J Cancer 2017; 141: 129–142.
Google Scholar | Crossref | Medline50. Levy-Lahad, E, Catane, R, Eisenberg, S, et al. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 1997; 60: 1059–1067.
Google Scholar | Medline51. Gallardo, M, Silva, A, Rubio, L, et al. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlations. Breast Cancer Res Treat